Skip to main content
Top

Clinical & Experimental Metastasis

Issue 3/2008

Content (9 Articles)

Research paper

Impact of sentinel lymphadenectomy on survival in a murine model of melanoma

Robert B. Rebhun, Alexander J. F. Lazar, Isaiah J. Fidler, Jeffrey E. Gershenwald

Research Paper

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

Su Young Kim, Chih Hung Lee, Brieanne V. Midura, Choh Yeung, Arnulfo Mendoza, Sung Hyeok Hong, Ling Ren, Donald Wong, Walter Korz, Ahmed Merzouk, Hassan Salari, Hong Zhang, Sam T. Hwang, Chand Khanna, Lee J. Helman

Research Paper

Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes

Elena Afrimzon, Assaf Deutsch, Yana Shafran, Naomi Zurgil, Judith Sandbank, Itzhak Pappo, Mordechai Deutsch

Research Paper

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells

Chiara Marconi, Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri, Lido Calorini

Research Paper

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen

Christian Schindlbeck, Julia Stellwagen, Udo Jeschke, Uwe Karsten, Brigitte Rack, Wolfgang Janni, Julia Jückstock, Augustinos Tulusan, Harald Sommer, Klaus Friese

Research Paper

The laminin α-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells

Jean A. Engbring, Rydhwana Hossain, Sherilyn J. VanOsdol, Benjamin Kaplan-Singer, Michael Wu, Suguru Hibino, Jennifer E. Koblinski

Research Paper

Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential

Zhongyong Li, Zhiyi Zhou, Henry J. Donahue

Research Paper

Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin

Ergül Eyol, Annemarie Boleij, Rachel R. Taylor, Andrew L. Lewis, Martin R. Berger

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine